Hematopoietic Agents Market Global Outlook and Overview 2017-2025
Hematopoiesis is a process of continuous replacement of most mature blood cells. New produced blood cells must be adequate to meet the basic demand of body. Hematopoiesis process needs an ample supply of minerals (e.g., iron, copper, and cobalt) and vitamins (e.g., vitamin B12, folic acid, ascorbic acid, pyridoxine, and riboflavin). Normal hematopoiesis process produces more than 400 billion blood cells each day, this production can be increased several-fold with increased demand by hematopoietic agents. If hematopoiesis slowdowns or any disorder occurs which results in a deficiency of normal blood cells which is lead to anemia, thrombocytopenia or neutropenia. Hematopoietic agents Market are intended to improve the quality and quantity of the blood, by increasing the hemoglobin level and the number of erythrocytes leucocytes and platelets. Hematopoietic agents Market are mostly used in the in the treatment of anemia. Exhaustion and tiredness, headache, dyspnoea, dry and rough skin, tachycardia, restless legs syndrome, neurocognitive dysfunction, hemodynamic instability, brittle nails or hair loss, and yellow sallow skin are the major symptoms of hematopoiesis disorder.
Read Report Overview @ https://www.transparencymarketresearch.com/hematopoietic-agents-market.html
Increasing the risk of haemodilution in pregnancy drive the hematopoietic agents market. Changes in lifestyle are playing a major role in propelling the global hematopoietic agents market. According to National Heart, Lung, and Blood Institute (NHLBI) report, an estimated 20% women of childbearing age have iron-deficiency anemia. Rapid or irregular heartbeat due to low amount oxygen blood leads to major complications such as heart failure or an enlarged heart. Additionally, Availability of large patient pool, expansion of the health care industry, and rise in various country’s government investment to improve health care are anticipated to propel the market. High cost, high competition among existing players, stringent government regulation for approval of the product and lack of awareness are key restraints of the market.
The global hematopoietic agents market is can be segmented based on, application, distribution channel, and region. In terms of application, the global hematopoietic agents market can be divided into anemia, thrombocytopenia, neutropenia, cancer treatment, marrow transplantation and others blood disorders. According to World Health Organization, in 2011 estimates that anemia affects around 800 million children and women globally. The cancer segment is likely to expand at the fastest growth rate during the forecast period from 2017 to 2025. Based on distribution channel, the global hematopoietic agents market can be categorized into hospitals pharmacies, retail pharmacies, dietary care centers and others. Rising prevalence of hematological disorders likely to boost the market in the near future.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40688
In terms of region, the global hematopoietic agents market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the largest market for hematopoietic agents, followed by Europe and Asia Pacific. The U.S. is a major contributor to the hematopoietic agents market in North America in terms of revenue. The market in Asia Pacific is expanding rapidly due to increase in a number of patients. However, Asia Pacific and Africa are projected to be the most attractive markets in the near future, especially emerging economies such as such as Brazil, India, China, and Japan, due to its better health care infrastructure, economic growth, expanding and developing private health care sector, improving insurance payers, and increasing awareness among population.
Key players in the global hematopoietic agents market include Amgen Inc., Apotex, Luitpold Pharmaceuticals Inc., Novartis AG, AMAG Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Acceleron Pharma, Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Johnson & Johnson, Akebia Therapeutics, Inc., Pfizer Inc., Pharmacosmos A/S. and others.
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=40688
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453